News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Elvina Almuradova: Treatment Algorithm For HER+/HER2- Metastatic Breast Cancer
Elvina Almuradova/X
May 16, 2025, 08:41

Elvina Almuradova: Treatment Algorithm For HER+/HER2- Metastatic Breast Cancer

Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared a post on X:

” 1L: AI or Fulv + CDK4/6i
2L:
  •  PI3K and ESR1 wt: Fulv + Everolimus / Abemaciclib
  •  ESR1 mut: Elacestrant
  •  PI3K mut: Fulv + Alpelisib / Capivasertib
3L+: Options incl. chemo, Elacestrant, Olaparib, T-DXd
4L+: SG, DATO-DXd, biomarkers”Elvina Almuradova

More posts featuring Elvina Almuradova

Breast Cancer cancer Elvina Almuradova MBC metastatic breast cancer OncoDaily Oncology
Special Coverage
Career
Jun 4, 2025, 17:30
Fellowship and Short-Term Training Opportunities Now Open at POEM Training Centers - POEM Group
Celebrities
Jun 4, 2025, 17:16
Jessie J Diagnosed with Early-Stage Breast Cancer: What Is the Prognosis?
Blog
Jun 4, 2025, 17:13
Katy Rezvani Has Been Appointed as AACR 2026 Program Committee Co-Chair and Elected to the Association of American Physicians
Blog
Jun 4, 2025, 17:07
Teresa Amaral: The Fantastic Faculty of The ASCO and ESMO Session at ASCO25 Congress
Blog
Jun 4, 2025, 17:02
Jennifer Buell Highlights Strategic Partnership Between Agenus and Zydus
Blog
Jun 4, 2025, 16:52
Olubukola Ayodele: I Leave ASCO25 Feeling Recharged Not Just By Data But By Direction
Insight
Jun 4, 2025, 16:33
Paolo Tarantino on Sara Tolaney’s Leadership and Mentorship at ASCO 2025
Blog
Jun 4, 2025, 16:33
Maryam Lustberg: Grateful For My MASCC Family
Insight
Jun 4, 2025, 16:30
Jasmine Kamboj Celebrated ASCO Advocacy Award with Team Minnesota at ASCO 2025
Blog
Jun 4, 2025, 16:27
Hadieh Eslampanah: Happy International Cancer Survivors Day 2025 - New Life and New Beginning
Oncolibrary
Jun 4, 2025, 16:20
IMMUNOSARC II Study Results: Sunitinib Plus Nivolumab Shows Promising Activity in Advanced Extraskeletal Myxoid Chondrosarcoma (EMC)
Blog
Jun 4, 2025, 15:56
SIOG Announces Interactive Geriatric Assessment Workshop for SIOG 2025